Teleflex Incorporated rose 2.61% in intraday trading, driven by the launch of Barrigel rectal spacer in Japan. The company announced that the product is now available for purchase following regulatory approval and insurance coverage acceptance. The spacer is designed to minimize harmful side effects of prostate radiation therapy, marking a significant advancement in medical technology.
Comments
No comments yet